John Leaman
Nessuna posizione attualmente
Patrimonio netto: - $ in data 31/03/2024
Profilo
John Harold Leaman worked as the Head of Corporate Development at InfaCare Pharmaceutical Corp.
in 2017.
He was the Chief Financial Officer and Head of Corporate Strategy at Selecta Biosciences, Inc. from 2017 to 2019.
From 2013 to 2016, he served as the Chief Financial Officer at Aevi Genomic Medicine, Inc. and was a Principal at Devon Park Bioventures.
He also worked as an Associate Principal at McKinsey & Co., Inc. Dr. Leaman's education includes an undergraduate degree from Elizabethtown College, a graduate degree from Oriel College, an MBA from The Wharton School of the University of Pennsylvania, and a doctorate from Perelman School of Medicine.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
15/03/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Precedenti posizioni note di John Leaman
Società | Posizione | Fine |
---|---|---|
IPI LEGACY LIQUIDATION CO | Director of Finance/CFO | 10/03/2023 |
CARTESIAN THERAPEUTICS, INC. | Director of Finance/CFO | 31/03/2019 |
InfaCare Pharmaceutical Corp.
InfaCare Pharmaceutical Corp. BiotechnologyHealth Technology InfaCare Pharmaceutical Corp. develops and commercializes proprietary pharmaceuticals for the neonatal and pediatric patient population. It offers Stanate, a heme oxygenase inhibitor for the treatment of infantile jaundice or hyperbilirubinemia. The company was founded by Robert A. Vukovich on July 5, 2005 and is headquartered in Trevose, PA. | Corporate Officer/Principal | 01/09/2017 |
AEVI GENOMIC MEDICINE, INC. | Director of Finance/CFO | 09/02/2016 |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Formazione di John Leaman
Elizabethtown College | Undergraduate Degree |
Oriel College | Graduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Perelman School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
IPI LEGACY LIQUIDATION CO | Health Technology |
Aziende private | 5 |
---|---|
InfaCare Pharmaceutical Corp.
InfaCare Pharmaceutical Corp. BiotechnologyHealth Technology InfaCare Pharmaceutical Corp. develops and commercializes proprietary pharmaceuticals for the neonatal and pediatric patient population. It offers Stanate, a heme oxygenase inhibitor for the treatment of infantile jaundice or hyperbilirubinemia. The company was founded by Robert A. Vukovich on July 5, 2005 and is headquartered in Trevose, PA. | Health Technology |
Selecta Biosciences, Inc.
Selecta Biosciences, Inc. BiotechnologyHealth Technology Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its portfolio includes pipeline, autoimmune, gene therapy, and biologic therapy. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian on December 10, 2007 and is headquartered in Watertown, MA. | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
Aevi Genomic Medicine, Inc.
Aevi Genomic Medicine, Inc. Pharmaceuticals: MajorHealth Technology Aevi Genomic Medicine, Inc. is a clinical stage biopharmaceutical company, which engaged in the discovery of treatments for rare and orphan diseases. Its research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP). The company was founded by Andrew Leonard Pearlman on January 27, 2000 and is headquartered in Wayne, PA. | Health Technology |
Devon Park Bioventures
Devon Park Bioventures Investment ManagersFinance Devon Park Bioventures (Devon Park Bioventures) is a venture capital firm founded in 2006. The firm is headquartered in Pennsylvania, United States. | Finance |
- Borsa valori
- Insiders
- John Leaman